40.50
Revolution Medicines Inc (RVMD) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
|
9.95%
264.71
|
240.76 | 216.31 | 175.71 | 156.64 |
Operating Income/Loss |
9.95%
-264.71
|
-240.76 | -216.31 | -175.71 | -156.64 |
Nonoperating Income/Loss |
38.10%
16.93
|
27.34 | 20.99 | 19.42 | 23.41 |
Income/Loss From Continuing Operations Before Tax |
16.11%
-247.79
|
-213.42 | -195.32 | -156.29 | -133.23 |
Income/Loss From Continuing Operations After Tax |
16.11%
-247.79
|
-213.42 | -194.57 | -156.29 | -133.23 |
|
16.11%
-247.79
|
-213.42 | -194.57 | -156.29 | -133.23 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.23%
188.58
|
188.15 | 2.1613 | 166.84 | 165.14 |
Diluted Average Shares |
0.23%
188.58
|
188.15 | 2.1613 | 166.84 | 165.14 |
Basic Earnings Per Share |
15.93%
-1.31
|
-1.13 | -1.13 | -0.94 | -0.81 |
Diluted Earnings Per Share |
15.93%
-1.31
|
-1.13 | -1.13 | -0.94 | -0.81 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):